The topping-out wreath has been hoisted above the future production facility at the headquarters of Biotest AG in Dreieich, Germany since October 21, 2015. The specialist for pharma products made from blood plasma has been growing steadily for years. For this reason, the existing site is being expanded to allow the processing of twice as much blood plasma. The pharmaceutical company is investing a total of some €250 million in the upgrade of the facility. Drees & Sommer is coordinating the project and supporting Biotest’s overall project management.
From 2017, about 300 additional staff will take up work in the new premises in Dreieich, Hessen. In addition to a new central production facility, there will also be space for offices and laboratories as well as warehousing for raw materials and finished goods. In addition, extensive infrastructure will be provided for media supply and disposal. A new employee multi-story car park with 700 parking spaces has already been built.
The pharmaceutical specialists have integrated the Drees & Sommer Life Sciences experts into their project management team to ensure rapid completion of the facility. The Stuttgart experts have been supporting the upgrade since the initial concept phase and are assisting with all aspects of planning, procurement, and implementation of production Systems.